Evolving role of MeCP2 in Rett syndrome and autism

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Armstrong DD, Dunn K, Antalffy B: Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J. Neuropathol. Exp. Neurol.57(11),1013–1017 (1998).Crossref, Medline, CAS, Google Scholar
• 2  Raymond GV, Bauman ML, Kemper TL: Hippocampus in autism: a Golgi analysis. Acta Neuropathol.91(1),117–119 (1996).Crossref, Medline, CAS, Google Scholar
• 3  Belichenko PV, Oldfors A, Hagberg B et al.: Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport5(12),1509–1513 (1994).Crossref, Medline, CAS, Google Scholar
• 4  Pickett J, London E: The neuropathology of autism: a review. J. Neuropathol. Exp. Neurol.64(11),925–935 (2005).Crossref, Medline, Google Scholar
• 5  Armstrong DD: Neuropathology of Rett syndrome. J. Child Neurol.20(9),747–753 (2005).Crossref, Medline, Google Scholar
• 6  Amir RE, Van den Veyver IB, Wan M et al.: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2. Nat. Genet.23(2),185–188 (1999).Crossref, Medline, CAS, Google Scholar
• 7  Jones PL, Veenstra GJ, Wade PA et al.: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet.19(2),187–191 (1998).Crossref, Medline, CAS, Google Scholar
• 8  Nan X, Ng HH, Johnson CA et al.: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature393(6683),386–389 (1998).Crossref, Medline, CAS, Google Scholar
• 9  Zhou Z, Hong EJ, Cohen S et al.: Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron52(2),255–269 (2006).▪ Demonstrated that MeCP2 is phosphorylated in response to neuronal activity, resulting in a change to Bdnf expression and neuronal maturation.Crossref, Medline, CAS, Google Scholar
• 10  Yasui DH, Peddada S, Bieda MC et al.: Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl Acad. Sci. USA104(49),19416–19421 (2007).▪▪ This chromatin immunoprecipitation (ChIP)-chip and epigenomic analysis of MeCP2 binding sites in tiled genomic regions and promoters genome-wide challenged the expectation that MeCP2 would be primarily bound to inactive promoters.Crossref, Medline, CAS, Google Scholar
• 11  Chahrour M, Jung SY, Shaw C et al.: MeCP2, a key contributor to neurological disease, activates and represses transcription. Science320(5880),1224–1229 (2008).▪▪ This study showed that MeCP2 associates with the transcriptional activator CREB1 and, for the majority of identified target genes, activates rather than represses expression.Crossref, Medline, CAS, Google Scholar
• 12  Suzuki MM, Bird A: DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet.9(6),465–476 (2008).Crossref, Medline, CAS, Google Scholar
• 13  Bernstein E, Hake SB: The nucleosome: a little variation goes a long way. Biochem. Cell Biol.84(4),505–517 (2006).Crossref, Medline, CAS, Google Scholar
• 14  Zaidi SK, Young DW, Choi JY et al.: The dynamic organization of gene-regulatory machinery in nuclear microenvironments. EMBO Rep.6(2),128–133 (2005).Crossref, Medline, CAS, Google Scholar
• 15  Galande S, Purbey PK, Notani D et al.: The third dimension of gene regulation: organization of dynamic chromatin loopscape by SATB1. Curr. Opin. Genet. Dev.17(5),408–414 (2007).Crossref, Medline, CAS, Google Scholar
• 16  Cremer T, Cremer M, Dietzel S et al.: Chromosome territories – a functional nuclear landscape. Curr. Opin. Cell Biol.18(3),307–316 (2006).Crossref, Medline, CAS, Google Scholar
• 17  Jirtle RL, Skinner MK: Environmental epigenomics and disease susceptibility. Nat. Rev. Genet.8(4),253–262 (2007).Crossref, Medline, CAS, Google Scholar
• 18  McGrath J, Solter D: Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell37(1),179–183 (1984).Crossref, Medline, CAS, Google Scholar
• 19  Eggermann T: Silver–Russell and Beckwith–Wiedemann syndromes: opposite (epi)mutations in 11p15 result in opposite clinical pictures. Horm. Res.71(Suppl. 2),30–35 (2009).Medline, CAS, Google Scholar
• 20  Lalande M, Calciano MA: Molecular epigenetics of Angelman syndrome. Cell. Mol. Life Sci.64(7–8),947–960 (2007).Crossref, Medline, CAS, Google Scholar
• 21  Peters J, Robson JE: Imprinted noncoding RNAs. Mamm. Genome19(7–8),493–502 (2008).Crossref, Medline, CAS, Google Scholar
• 22  Edwards CA, Ferguson-Smith AC: Mechanisms regulating imprinted genes in clusters. Curr. Opin. Cell Biol.19(3),281–289 (2007).Crossref, Medline, CAS, Google Scholar
• 23  Maeda N, Hayashizaki Y: Genome-wide survey of imprinted genes. Cytogenet. Genome Res.113(1–4),144–152 (2006).Crossref, Medline, CAS, Google Scholar
• 24  Gimelbrant A, Hutchinson JN, Thompson BR et al.: Widespread monoallelic expression on human autosomes. Science318(5853),1136–1140 (2007).▪ Epigenomic study showing that monoallelic expression is not limited to imprinted genes.Crossref, Medline, CAS, Google Scholar
• 25  Payer B, Lee JT: X chromosome dosage compensation: how mammals keep the balance. Annu. Rev. Genet.42,733–772 (2008).Crossref, Medline, CAS, Google Scholar
• 26  Chaumeil J, Le Baccon P, Wutz A et al.: A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes Dev.20(16),2223–2237 (2006).Crossref, Medline, CAS, Google Scholar
• 27  Clemson CM, Hall LL, Byron M et al.: The X chromosome is organized into a gene-rich outer rim and an internal core containing silenced nongenic sequences. Proc. Natl Acad. Sci. USA103(20),7688–7693 (2006).Crossref, Medline, CAS, Google Scholar
• 28  Carrel L, Willard HF: X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature434(7031),400–404 (2005).Crossref, Medline, CAS, Google Scholar
• 29  Hellman A, Chess A: Gene body-specific methylation on the active X chromosome. Science315(5815),1141–1143 (2007).▪ Epigenomic study that countered the dogma that genes on the active X chromosome are hypomethylated compared with the inactive allele.Crossref, Medline, CAS, Google Scholar
• 30  Weber M, Hellmann I, Stadler MB et al.: Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet.39(4),457–466 (2007).▪ A DNA methylation ChIP (MeDIP) analysis of promoters genome-wide showing that dense CpG islands are mostly unmethylated, even when inactive.Crossref, Medline, CAS, Google Scholar
• 31  Rauch TA, Wu X, Zhong X et al.: A human B cell methylome at 100-base pair resolution. Proc. Natl Acad. Sci. USA106(3),671–678 (2009).▪ A gene-biased methylated DNA enrichment method on genome tiling arrays shows the correlation of dense methylation in active gene-dense R bands and a correlation of gene body methylation with gene activity.Crossref, Medline, CAS, Google Scholar
• 32  Rollins RA, Haghighi F, Edwards JR et al.: Large-scale structure of genomic methylation patterns. Genome Res.16(2),157–163 (2006).▪ A combined restriction enzyme-based approach that covered repetitive and nonrepetitive sequences, and demonstrated that the human genome is globally and extensively methylated, with short hypomethylated domains enriched in gene promoters and CpG islands.Crossref, Medline, CAS, Google Scholar
• 33  Irizarry RA, Ladd-Acosta C, Wen B et al.: The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet.41(2),178–186 (2009).▪ Tissue-specific methylation differences are primarily found at the ‘shores’ of CpG islands, not within CpG islands.Crossref, Medline, CAS, Google Scholar
• 34  Heintzman ND, Hon GC, Hawkins RD et al.: Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature459(7243),108–112 (2009).Crossref, Medline, CAS, Google Scholar
• 35  Meissner A, Mikkelsen TS, Gu H et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature454(7205),766–770 (2008).▪▪ A successful high-throughput bisulfite sequencing analysis of mammals using reduced representation of primarily CpG islands.Crossref, Medline, CAS, Google Scholar
• 36  LaSalle JM: Paradoxical role of methyl-CpG-binding protein 2 in Rett syndrome. Curr. Top. Dev. Biol.59,61–86 (2004).Crossref, Medline, CAS, Google Scholar
• 37  Nan X, Campoy FJ, Bird A: MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell88(4),471–481 (1997).Crossref, Medline, CAS, Google Scholar
• 38  Yu F, Thiesen J, Stratling WH: Histone deacetylase-independent transcriptional repression by methyl- CpG-binding protein 2. Nucleic Acids Res.28(10),2201–2206 (2000).Crossref, Medline, CAS, Google Scholar
• 39  Muller C, Readhead C, Diederichs S et al.: Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent. Mol. Cell Biol.20(9),3316–3329 (2000).Crossref, Medline, CAS, Google Scholar
• 40  Konduri SD, Srivenugopal KS, Yanamandra N et al.: Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene22(29),4509–4516 (2003).Crossref, Medline, CAS, Google Scholar
• 41  Ramachandran K, Gopisetty G, Gordian E et al.: Methylation-mediated repression of GADD45a in prostate cancer and its role as a potential therapeutic target. Cancer Res.69(4),1527–1535 (2009).Crossref, Medline, CAS, Google Scholar
• 42  Klose RJ, Bird AP: MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodelling complex. J. Biol. Chem.279(45),46490–46496 (2004).Crossref, Medline, CAS, Google Scholar
• 43  Balmer D, Arredondo J, Samaco RC et al.: MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum. Genet.110(6),545–552 (2002).Crossref, Medline, CAS, Google Scholar
• 44  Gartler SM, Varadarajan KR, Luo P et al.: Normal histone modifications on the inactive X chromosome in ICF and Rett syndrome cells: implications for methyl-CpG binding proteins. BMC Biol.2(1),21 (2004).Crossref, Medline, Google Scholar
• 45  Samaco RC, Hogart A, LaSalle JM: Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.Hum. Mol. Genet.14,483–492 (2005).▪ Analysis of mouse and human brain samples that showed an overlapping pathway of Rett syndrome, 15q11–13 imprinted disorders and idiopathic autism.Crossref, Medline, CAS, Google Scholar
• 46  Li E, Beard C, Jaenisch R: Role for DNA methylation in genomic imprinting. Nature366(6453),362–365 (1993).Crossref, Medline, CAS, Google Scholar
• 47  Tudor M, Akbarian S, Chen RZ et al.: Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl Acad. Sci. USA99(24),15536–15541 (2002).Crossref, Medline, CAS, Google Scholar
• 48  Traynor J, Agarwal P, Lazzeroni L et al.: Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med. Genet.3(1),12 (2002).Crossref, Medline, Google Scholar
• 49  Fuks F, Hurd PJ, Wolf D et al.: The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem.278(6),4035–4040 (2003).Crossref, Medline, CAS, Google Scholar
• 50  Chen WG, Chang Q, Lin Y et al.: Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science302(5646),885–889 (2003).Crossref, Medline, CAS, Google Scholar
• 51  Martinowich K, Hattori D, Wu H et al.: DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science302(5646),890–893 (2003).Crossref, Medline, CAS, Google Scholar
• 52  Nuber UA, Kriaucionis S, Roloff TC et al.: Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum. Mol. Genet.14(15),2247–2256 (2005).Crossref, Medline, CAS, Google Scholar
• 53  Horike S, Cai S, Miyano M et al.: Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet.37(1),31–40 (2005).▪ Demonstrated a new role for MeCP2 in the formation of silent chromatin loops in an imprinted locus relevant to GABA synthesis.Crossref, Medline, CAS, Google Scholar
• 54  Peddada S, Yasui DH, LaSalle JM: Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum. Mol. Genet.15(12),2003–2014 (2006).Crossref, Medline, CAS, Google Scholar
• 55  McGill BE, Bundle SF, Yaylaoglu MB et al.: Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA103(48),18267–18272 (2006).Crossref, Medline, CAS, Google Scholar
• 56  Deng V, Matagne V, Banine F et al.: FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum. Mol. Genet.16(6),640–650 (2007).Crossref, Medline, CAS, Google Scholar
• 57  Jordan C, Li HH, Kwan HC et al.: Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med. Genet.8,36 (2007).Crossref, Medline, Google Scholar
• 58  Urdinguio RG, Lopez-Serra L, Lopez-Nieva P et al.: Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS ONE3(11),e3669 (2008).Crossref, Medline, Google Scholar
• 59  Chang Q, Khare G, Dani V et al.: The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron49(3),341–348 (2006).Crossref, Medline, CAS, Google Scholar
• 60  Bowen NJ, Palmer MB, Wade PA: DNA damage repair and transcription chromosomal regulation by MeCP2: structural and enzymatic considerations. Cell Mol. Life Sci.61(17),2163–2167 (2004).Crossref, Medline, CAS, Google Scholar
• 61  Georgel PT, Horowitz-Scherer RA, Adkins N et al.: Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem.278(34),32181–32188 (2003).Crossref, Medline, CAS, Google Scholar
• 62  Harikrishnan KN, Chow MZ, Baker EK et al.: Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat. Genet.37(3),254–264 (2005).Crossref, Medline, CAS, Google Scholar
• 63  Nan X, Hou J, Maclean A et al.: Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc. Natl Acad. Sci. USA104(8),2709–2714 (2007).Crossref, Medline, CAS, Google Scholar
• 64  Young JI, Hong EP, Castle JC et al.: Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl Acad. Sci. USA102(49),17551–17558 (2005).Crossref, Medline, CAS, Google Scholar
• 65  Miyano M, Horike S, Cai S et al.: DLX5 expression is monoallelic and Dlx5 is up-regulated in the Mecp2-null frontal cortex. J. Cell Mol. Med.12(4),1188–1191 (2008).Crossref, Medline, CAS, Google Scholar
• 66  Schule B, Li HH, Fisch-Kohl C et al.: DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency. Am. J. Hum. Genet.81(3),492–506 (2007).Crossref, Medline, CAS, Google Scholar
• 67  Lewis JD, Meehan RR, Henzel WJ et al.: Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell69(6),905–914 (1992).Crossref, Medline, CAS, Google Scholar
• 68  Klose RJ, Sarraf SA, Schmiedeberg L et al.: DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell19(5),667–678 (2005).Crossref, Medline, CAS, Google Scholar
• 69  Lam C, Yeung W, Ko C et al.: Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J. Med. Genet.37(12),E41 (2000).Crossref, Medline, CAS, Google Scholar
• 70  Dotti MT, Orrico A, De Stefano N et al.: A Rett syndrome MECP2 mutation that causes mental retardation in men. Neurology58(2),226–230 (2002).Crossref, Medline, CAS, Google Scholar
• 71  Carney RM, Wolpert CM, Ravan SA et al.: Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr. Neurol.28(3),205–211 (2003).Crossref, Medline, Google Scholar
• 72  Kleefstra T, Yntema HG, Nillesen WM et al.: MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics. Eur. J. Hum. Genet.12(1),24–28 (2004).Crossref, Medline, CAS, Google Scholar
• 73  Hammer S, Dorrani N, Dragich J et al.: The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev.8(2),94–98 (2002).Crossref, Medline, Google Scholar
• 74  Van Esch H, Bauters M, Ignatius J et al.: Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet.77(3),442–453 (2005).Crossref, Medline, CAS, Google Scholar
• 75  Hertz-Picciotto I, Delwiche L: The rise in autism and the role of age at diagnosis. Epidemiology20(1),84–90 (2009).Crossref, Medline, Google Scholar
• 76  Geschwind DH: Autism: many genes, common pathways? Cell135(3),391–395 (2008).Crossref, Medline, CAS, Google Scholar
• 77  Morrow EM, Yoo SY, Flavell SW et al.: Identifying autism loci and genes by tracing recent shared ancestry. Science321(5886),218–223 (2008).Crossref, Medline, CAS, Google Scholar
• 78  Cook EH, Jr. Scherer SW: Copy-number variations associated with neuropsychiatric conditions. Nature455(7215),919–923 (2008).Crossref, Medline, CAS, Google Scholar
• 79  Feuk L, Carson AR, Scherer SW: Structural variation in the human genome. Nat. Rev. Genet.7(2),85–97 (2006).Crossref, Medline, CAS, Google Scholar
• 80  Iafrate AJ, Feuk L, Rivera MN et al.: Detection of large-scale variation in the human genome. Nat. Genet.36(9),949–951 (2004).Crossref, Medline, CAS, Google Scholar
• 81  Sebat J, Lakshmi B, Troge J et al.: Large-scale copy number polymorphism in the human genome. Science305(5683),525–528 (2004).Crossref, Medline, CAS, Google Scholar
• 82  Stone JL, O’Donovan MC, Gurling H et al.: Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature455(7210),237–241 (2008).Crossref, Medline, CAS, Google Scholar
• 83  Sebat J, Lakshmi B, Malhotra D et al.: Strong association of de novo copy number mutations with autism. Science316(5823),445–449 (2007).Crossref, Medline, CAS, Google Scholar
• 84  Stefansson H, Rujescu D, Cichon S et al.: Large recurrent microdeletions associated with schizophrenia. Nature455(7210),232–236 (2008).Crossref, Medline, CAS, Google Scholar
• 85  Miller DT, Shen Y, Weiss LA et al.: Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatirc disorders. J. Med. Genet.46(4),242–248 (2008).Crossref, Medline, Google Scholar
• 86  Christian SL, Fantes JA, Mewborn SK et al.: Large genomic duplicons map to sites of instability in the Prader-Willi/Angelman syndrome chromosome region (15q11-q13). Hum. Mol. Genet.8(6),1025–1037 (1999).Crossref, Medline, CAS, Google Scholar
• 87  Ramocki MB, Zoghbi HY: Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature455(7215),912–918 (2008).Crossref, Medline, CAS, Google Scholar
• 88  Hogart A, Wu D, Lasalle JM et al.: The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol. Dis. (2008) (Epub ahead of print).Medline, Google Scholar
• 89  Cook EH, Jr. Lindgren V, Leventhal BL et al.: Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet.60(4),928–934 (1997).Medline, CAS, Google Scholar
• 90  Mohandas TK, Park JP, Spellman RA et al.: Paternally derived de novo interstitial duplication of proximal 15q in a patient with developmental delay. Am. J. Med. Genet.82(4),294–300 (1999).Crossref, Medline, CAS, Google Scholar
• 91  Mao R, Jalal SM, Snow K et al.: Characteristics of two cases with dup(15)(q11.2-q12): one of maternal and one of paternal origin. Genet. Med.2(2),131–135 (2000).Crossref, Medline, CAS, Google Scholar
• 92  Veltman MW, Thompson RJ, Craig EE et al.: A paternally inherited duplication in the Prader–Willi/Angelman syndrome critical region: a case and family study. J. Autism. Dev. Disord.35(1),117–127 (2005).Crossref, Medline, Google Scholar
• 93  Depienne C, Moreno-De-Luca D, Heron D et al.: Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol. Psychiatry66(4),349–359 (2009).Crossref, Medline, CAS, Google Scholar
• 94  Nagarajan RP, Hogart AR, Gwye Y et al.: Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics1(4),172–182 (2006).Crossref, Google Scholar
• 95  Samaco RC, Nagarajan RP, Braunschweig D et al.: Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum. Mol. Genet.13(6),629–639 (2004).Crossref, Medline, CAS, Google Scholar
• 96  Makedonski K, Abuhatzira L, Kaufman Y et al.: MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum. Mol. Genet.14(8),1049–1058 (2005).Crossref, Medline, CAS, Google Scholar
• 97  Jiang YH, Sahoo T, Michaelis RC et al.: A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am. J. Med. Genet.131(1),1–10 (2004).Crossref, Medline, Google Scholar
• 98  Thatcher K, Peddada S, Yasui D et al.: Homologous pairing of 15q11–13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples. Hum. Mol. Genet.14,785–797 (2005).Crossref, Medline, CAS, Google Scholar
• 99  Hogart A, Nagarajan RP, Patzel KA et al.: 15q11–13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum. Mol. Genet.16(6),691–703 (2007).Crossref, Medline, CAS, Google Scholar
• 100  Hogart A, Leung KN, Wang NJ et al.: Chromosome 15q11–13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J. Med. Genet.46(2),86–93 (2009).Crossref, Medline, CAS, Google Scholar
• 101  Swanberg SE, Nagarajan RP, Peddada S et al.: Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism. Hum. Mol. Genet.18(3),525–534 (2009).Crossref, Medline, CAS, Google Scholar
• 102  Moretti P, Bouwknecht JA, Teague R et al.: Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum. Mol. Genet.14(2),205–220 (2005).Crossref, Medline, CAS, Google Scholar
• 103  Moretti P, Levenson JM, Battaglia F et al.: Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci.26(1),319–327 (2006).Crossref, Medline, CAS, Google Scholar
• 104  Samaco RC, Fryer JD, Ren J et al.: A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum. Mol. Genet.17(12),1718–1727 (2008).Crossref, Medline, CAS, Google Scholar
• 105  Dolinoy DC, Weidman JR, Jirtle RL: Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod. Toxicol.23(3),297–307 (2007).Crossref, Medline, CAS, Google Scholar
• 106  Simonis M, Kooren J de Laat W: An evaluation of 3C-based methods to capture DNA interactions. Nat. Methods4(11),895–901 (2007).Crossref, Medline, CAS, Google Scholar
• 107  Simonis M, Klous P, Splinter E et al.: Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat. Genet.38(11),1348–1354 (2006).Crossref, Medline, CAS, Google Scholar
• 108  von Bubnoff A: Next-generation sequencing: the race is on. Cell132(5),721–723 (2008).Crossref, Medline, CAS, Google Scholar
• 109  Ansorge WJ: Next-generation DNA sequencing techniques. N. Biotechnol.25(4),195–203 (2009).Crossref, Medline, CAS, Google Scholar
• 110  Lister R, O’Malley RC, Tonti-Filippini J et al.: Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell133(3),523–536 (2008).Crossref, Medline, CAS, Google Scholar
• 111  Cokus SJ, Feng S, Zhang X et al.: Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature452(7184),215–219 (2008).Crossref, Medline, CAS, Google Scholar
• 112  Kriaucionis S, Heintz N: The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science324(5929),929–930 (2009).▪▪ A sixth base in the mammalian genome of 5-hydroxymethylcytidine is identified and found to be enriched in brain.Crossref, Medline, CAS, Google Scholar
• 113  Tahiliani M, Koh KP, Shen Y et al.: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science324(5929),930–935 (2009).Crossref, Medline, CAS, Google Scholar
• 114  Valinluck V, Tsai HH, Rogstad DK et al.: Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res.32(14),4100–4108 (2004).Crossref, Medline, CAS, Google Scholar